Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer - Gong, Liming; Zhao, Heming; Chen, Liqing; Liu, Yanhong; Wu, Hao; Liu, Chao; Feng, Jing; Liu, Chenfei; Xiao, Congcong; Wang, Qiming; Jin, Mingji; Gao, Zhonggao; et al. (Pharmaceutics, 2025)
Keywords: Adjuvant treatment; Apoptosis; Biocompatibility; Cancer; Cell culture; Colorectal cancer; doxorubicin; Drug delivery systems; Drug therapy; Gastrointestinal diseases; Hemodialysis; Hydrogen-ion concentration; Ligands; LT peptide; Nanoparticles; NMR; Nuclear magnetic resonance; Particle size; Peptides; pH-sensitive release; Polyethylene glycol; targeted tumor therapy; Toxicity; Tumors; zeolitic imidazolate framework-8; Zinc; Massachusetts; China; California; Beijing China; United States--US; Shanghai China; LT peptide; colorectal cancer; doxorubicin; zeolitic imidazolate framework-8; targeted tumor therapy; pH-sensitive release